Advertisement

CNS-Neurology Companies in BioPortfolio's Corporate Database - Page: 2Twitter RSS

21:23 EDT 22nd May 2013 | BioPortfolio

CNS-Neurology company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest CNS-Neurology companies that have been added to our BioPortfolio's life-science corporate directory.

Search For More CNS-Neurology Companies

If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More CNS-Neurology Companies.

More Information about CNS-Neurology on BioPortfolio

We have published hundreds of CNS-Neurology news stories on BioPortfolio along with dozens of CNS-Neurology Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about CNS-Neurology for you to read.

Showing "neurology nervous" Companies 26 to 50 of 308

Saturday 4th May 2013

Biogen Idec and Abbott

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates...

Biogen Idec and Portola Pharmaceuticals

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market therapies for serious diseases with a focus on neurology, immunology and hemophilia. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates...

Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company’s extensive expertise in product development has been built over the past 20 years: initially as a stand alone development organization, then as a U.S. subsid...

SAGE Therapeutics

SAGE Therapeutics is a central nervous system (CNS) product focused company building a portfolio of new therapies to meet the growing unmet need in a range of CNS disorders, including schizophrenia, depression, pain and traumatic brain injury. SAGE Therapeutics’ proprietary Positive and Negative Allosteric Modulator (PANAM) chemistry platform targets the...

Monmouth Medical Center

Located in Long Branch, N.J., Monmouth Medical Center, along with the Children’s Hospital at Monmouth Medical Center, is one of New Jersey's largest academic medical centers and has been a teaching affiliate of Philadelphia’s Drexel University College of Medicine for more than 40 years. From its earliest days, Monmouth Medical Center has been a leader...

BioLineRx Ltd. and Compugen Ltd.

BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. BioLineRx’s current portfolio consists of five clinical stage candidates: BL-1020 for schizophrenia has commenced a Phase II/III study; BL-1040 for...

e-Therapeutics plc

e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on the science of complex systems. The Company’s discovery activity is focused in cancer and degenerative diseases of the nervous system and its development effort on four clinical candidates spa...

Cigna Corporation and Weill Cornell Physician Organization

Weill Cornell Physician Organization is an 850 member multi-specialty group practice in New York City. All Weill Cornell physicians are faculty members of Weill Cornell Medical College and attending physicians at New York-Presbyterian Hospital, one of the most comprehensive care facilities in the world. Weill Cornell physicians have consistently been leade...

Reviva Pharmaceuticals, Inc.

Reviva Pharmaceuticals Inc. (Reviva), located in San Jose, California, is an emerging clinical stage pharmaceutical company focused on developing a portfolio of internally discovered next generation safe and effective therapeutic drugs by using an integrated chemical genomics-based technology platform and proprietary chemistries. Reviva is currently focuse...

Nihon Kohden America Inc.

Nihon Kohden America was founded in 1979 as a wholly owned subsidiary of Nihon Kohden Corporation, Japan (founded in 1951). Nihon Kohden is a market leader in patient monitoring, sleep assessment, neurology and cardiology instrumentation. Its products are distributed to hospitals, physician’s practices, mobile services, and outpatient and surgery cent...

Axonia Medical

Axonia Medical is a privately owned-company located in Kalamazoo MI, founded by the University of Pennsylvania, Dr. Douglas H. Smith, The Robert A. Groff Endowed Professor and Vice Chairman for Research, Department of Neurosurgery, University of Pennsylvania, and Dr. Harry C. Ledebur, Fmr. Executive in Residence at Southwest Michigan Life Science Venture F...

EnVivo Pharmaceuticals, Inc.

EnVivo Pharmaceuticals, Inc. and its subsidiaries (“EnVivo Pharmaceuticals” or “EnVivo”) are dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system (CNS). EnVivo Pharmaceuticals, Inc. is a biotech company located in Watertown, Mass. The company’s focus is on building an...

Takeda Pharmaceuticals U.S.A. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology and cardiovascular disease treatments and seek to...

Cibiem, Inc.

Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation™ (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. Based in New York City, the company was co-founded by Mark Gelfand and Howard...

Premier Medical Associates

Formed in 1993, Premier Medical Associates has a team of over seventy providers in ten convenient locations offering specialties that include: asthma/allergy/immunology, behavioral health, cardiology, family medicine, gastroenterology, general and breast surgery, hospitalists, internal medicine, neurology, orthopedics, pediatrics, podiatry, radiology and s...

Takeda Pharmaceuticals U.S.A., Inc. and Affymax, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology, gastroenterology, and cardiovascular treatments and seek...

Accelerated Cure Project for Multiple Sclerosis

MS is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the United States and two million individuals worldwide. The disorder occurs twice as often in wom...

Amarantus BioScience, Inc.

Amarantus BioScience, Inc. is a development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat and/or diagnose Parkinson’s disease, Traumatic Brain Injury, Ischemic Heart Disease and other human diseases. The Co...

TransTech Pharma Inc.

TransTech Pharma is a privately held, clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of human therapeutics to fill unmet medical needs. The Company’s high-throughput drug discovery platform, Translational Technology®, translates the functional modulation of human proteins into safe and effective m...

CDH Proton Center

CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...

John Muir Health

John Muir Health is a not-for-profit organization that includes two of the largest medical centers in Contra Costa County: John Muir Medical Center - Walnut Creek Campus, a 330-bed acute care medical center that serves as Contra Costa County's only designated trauma center; and John Muir Medical Center - Concord Campus, a 254-bed acute care medical center...

Sepracor Inc.

Sepracor Inc., an indirect, wholly-owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs.

Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and of late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Somaxon’s prod...

Eisai Inc.

Eisai Inc. was established in 1995 and is ranked among the top-20 U.S. pharmaceutical companies (based on retail sales). The company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2009 (year ended March 31, 2010) sales of approximately $3.9 billion....

Ipsen

Ipsen is a global biopharmaceutical group with total sales in excess of 1 billion euros in 2009, and total worldwide staff of more than 4,400. Its strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and primary care drugs, which significantly contribute to research financing. This strategy is also su...


More From BioPortfolio on "CNS-Neurology Companies in BioPortfolio's Corporate Database - Page: 2"

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks

Advertisement